JPH02182187A - Immobilized enzyme - Google Patents
Immobilized enzymeInfo
- Publication number
- JPH02182187A JPH02182187A JP7489A JP7489A JPH02182187A JP H02182187 A JPH02182187 A JP H02182187A JP 7489 A JP7489 A JP 7489A JP 7489 A JP7489 A JP 7489A JP H02182187 A JPH02182187 A JP H02182187A
- Authority
- JP
- Japan
- Prior art keywords
- enzyme
- nad
- immobilized
- adenine dinucleotide
- nicotinamide adenine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108010093096 Immobilized Enzymes Proteins 0.000 title claims abstract description 17
- 102000004190 Enzymes Human genes 0.000 claims abstract description 25
- 108090000790 Enzymes Proteins 0.000 claims abstract description 25
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims abstract description 19
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 claims abstract description 15
- 229950006238 nadide Drugs 0.000 claims abstract description 13
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 claims abstract description 11
- 238000005349 anion exchange Methods 0.000 claims abstract description 6
- 229910019142 PO4 Inorganic materials 0.000 claims abstract description 4
- 239000010452 phosphate Substances 0.000 claims abstract description 4
- ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 claims abstract description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims abstract description 3
- 230000003100 immobilizing effect Effects 0.000 claims abstract 2
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 abstract description 13
- 102000004722 NADPH Oxidases Human genes 0.000 abstract description 9
- 108010002998 NADPH Oxidases Proteins 0.000 abstract description 9
- XJLXINKUBYWONI-NNYOXOHSSA-O NADP(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-NNYOXOHSSA-O 0.000 abstract description 2
- 230000009257 reactivity Effects 0.000 abstract description 2
- 238000007086 side reaction Methods 0.000 abstract description 2
- 230000003647 oxidation Effects 0.000 abstract 2
- 238000007254 oxidation reaction Methods 0.000 abstract 2
- 229940101270 nicotinamide adenine dinucleotide (nad) Drugs 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 13
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 102000004316 Oxidoreductases Human genes 0.000 description 7
- 108090000854 Oxidoreductases Proteins 0.000 description 7
- 229920005654 Sephadex Polymers 0.000 description 6
- 239000012507 Sephadex™ Substances 0.000 description 6
- 239000008057 potassium phosphate buffer Substances 0.000 description 5
- 239000000872 buffer Substances 0.000 description 4
- 239000000356 contaminant Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 4
- 102000016938 Catalase Human genes 0.000 description 3
- 108010053835 Catalase Proteins 0.000 description 3
- 229920002271 DEAE-Sepharose Polymers 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 2
- 229930024421 Adenine Natural products 0.000 description 2
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241000186145 Corynebacterium ammoniagenes Species 0.000 description 2
- 241000589565 Flavobacterium Species 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 229960000643 adenine Drugs 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 238000012136 culture method Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 229960002715 nicotine Drugs 0.000 description 2
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 2
- 229910000160 potassium phosphate Inorganic materials 0.000 description 2
- 235000011009 potassium phosphates Nutrition 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000002525 ultrasonication Methods 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 241000590020 Achromobacter Species 0.000 description 1
- 241000589158 Agrobacterium Species 0.000 description 1
- 241000186146 Brevibacterium Species 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 241000193386 Lysinibacillus sphaericus Species 0.000 description 1
- 241000192041 Micrococcus Species 0.000 description 1
- 101100161696 Myxine glutinosa ache gene Proteins 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- -1 nicotinamide adenine nucleotide phosphate Chemical class 0.000 description 1
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- CIJQGPVMMRXSQW-UHFFFAOYSA-M sodium;2-aminoacetic acid;hydroxide Chemical compound O.[Na+].NCC([O-])=O CIJQGPVMMRXSQW-UHFFFAOYSA-M 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明はりアクタ−あるいは試薬等に使用される固定化
酵素に関する。DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to an immobilized enzyme used as a beam actor or reagent.
固定化酵素は酵素を用いた物質の変換を効率よく行うた
めに一般的に用いられている。しかしながら固定化酵素
を作成するに嶺っては、般に目的とする酵素をほぼ均一
にまで梢製し更に担体内に包括させたシ担体に結合させ
る等の工程が必要である。Immobilized enzymes are commonly used to efficiently convert substances using enzymes. However, in order to produce an immobilized enzyme, it is generally necessary to carry out steps such as preparing the enzyme of interest to a nearly uniform consistency and then bonding it to a carrier that is encapsulated within the carrier.
微生物は一般にほとんどの種において、本発明者らが先
に見出したように、構成的に還元型のニコチンアミドア
デニンジヌクレオチド又は還元型のニコチンアミドアデ
ニンジヌクレオチドホスフェートに作用して、酸化型の
ニコチンアミドアデニンジヌクレオチド又は酸化型のニ
コチンアミドアデニンジヌクレオチドホスフェート及び
過酸化水素を発生させる酵素〔以下NAD(P)Hオキ
シダーゼと略称する〕を生産するが、菌体が生産する総
タンパク質中に占めるNAD(P)Hオキシダーゼの割
合は少なく、本酵累を精製する段1昔でかなりの労力を
要するにもかかわらず精M酵素はカタラーゼ等の余分な
酵素及びその他の酵素あるいはタンパク質を含むことが
多い。In most species, microorganisms generally act on constitutively reduced nicotinamide adenine dinucleotide or reduced nicotinamide adenine dinucleotide phosphate to produce oxidized nicotine, as previously discovered by the present inventors. It produces an enzyme that generates amide adenine dinucleotide or oxidized nicotinamide adenine dinucleotide phosphate and hydrogen peroxide [hereinafter abbreviated as NAD(P)H oxidase], but the NAD that accounts for the total protein produced by the bacterial cell Although the proportion of (P)H oxidase is small and it takes considerable effort to purify the main fermentation product, the purified M enzyme often contains extra enzymes such as catalase and other enzymes or proteins.
上B己の様な夾雑物質が混在するNAD(P、)Hオキ
シダーゼは共存′$1J質の影響により、経時的にその
触媒効率が低下することがある。The catalytic efficiency of NAD(P,)H oxidase mixed with contaminants such as the above may decrease over time due to the influence of the coexisting quality.
共存物質の影響を避けるためには本酵素梢製時にアフィ
ニティークロマトグラフィーを利用するなどして高度に
#を表を行えば良いが工業的スケールで本酵素を精製す
るには費用の点で問題がろる。In order to avoid the effects of coexisting substances, it is possible to perform high-level chromatography by using affinity chromatography when producing this enzyme, but there are problems in terms of cost to purify this enzyme on an industrial scale. Roru.
上記したように、NAD(P)Hオキシダーゼは高度に
精製するには相当の労力を資し、かつ精製が不十分な場
合は本酵素の触媒機能に間鴎が生じる。As mentioned above, it takes considerable effort to purify NAD(P)H oxidase to a high degree, and if the purification is insufficient, the catalytic function of the enzyme is impaired.
本発明の目的は本酵素だけを特異的かつ容易に固定化し
た固定化酵素を提供することにあり、本固足化酵索はN
AD(P)Hを補酵素とする酵素、又はNAD(P)H
の定電に有用である。The purpose of the present invention is to provide an immobilized enzyme in which only the present enzyme is specifically and easily immobilized.
Enzyme with AD(P)H as coenzyme or NAD(P)H
Useful for constant voltage.
本発明を概説すれば、本発明は固定化NAD(P)Hオ
キシダーゼに関する発明であって、陰イオン交換基を持
つ担体に、還7[l:型のニコチンアミドアデニンジヌ
クレオチド又は還元型のニコチンアミドアデニンジヌク
レオチドホスフェートに作用して、酸化型のニコチンア
ミドアデニンジヌクレオチド又ニ酸化型のニコチンアミ
ドアデニンヌクレオチドホスフェート及びam化水素を
発生させるNAD(P)Hオキシダーゼを固定化させた
ことを特徴とする。To summarize the present invention, the present invention relates to immobilized NAD(P)H oxidase, in which reduced 7[l: type nicotinamide adenine dinucleotide or reduced nicotine It is characterized by immobilized NAD(P)H oxidase that acts on amide adenine dinucleotide phosphate to generate oxidized nicotinamide adenine dinucleotide or dioxidized nicotinamide adenine nucleotide phosphate and hydrogen atomide. do.
本発明者らは鋭意研究を行った結果、NAD(P)Hオ
キシダーゼが陰イオン交換基を有する担体に強固に結合
し、その結合は20%程度の食塩浴液中でも維持される
ことを見出した。一般に20%程度の食塩浴液中におい
ては、陰イオン交換基にイオン結合した物質は解離する
ので、NAD(P)Hオキシダーゼ及びその他のタンパ
ク質や核酸が同時に結合した陰イオン交換基を有する担
体を20%根度の食塩浴液で洗浄することにより、陰イ
オン交換基を有する担体にはNAD(P)Hオキシダー
ゼのみが特異的に固定化される。As a result of intensive research, the present inventors found that NAD(P)H oxidase binds firmly to a carrier having an anion exchange group, and that this binding is maintained even in a saline bath solution of about 20%. . Generally, in a saline bath solution of about 20%, substances ionically bound to anion exchange groups dissociate. By washing with a 20% saline solution, only NAD(P)H oxidase is specifically immobilized on the carrier having anion exchange groups.
本発明におけるNAD(P)Hオキシダーゼとしては例
えばブレビバクテリウム属(BrθVibac−ter
ium )、コリネバクテリウム属(Corynθti
aC−terium’、l、アースロバフタ−属(Ar
throbacter)、ミクロコツカス属(MiCr
OCoccu8人シュ、トモナス属(Pseuaomo
nae入アクロモバクタ−属(Achromobact
er )、アグロバクテリウム属(Agrobacte
rium )、フラボバクテリウム属(Flavoba
cterium )、ストレグトミセス属(Strep
tomyces )が生殖するex<特開昭65−44
882号、同63−157675号)、あるいはラクト
バチルス(Lactobacillus ) 由来の
rf1′累〔アグリカルチュラル・アンド・)ぐイ、t
Oシカル舎’rミスドリー(Agricutural
andBiol、ogica’l Chemistr
y ) 第25巻、第876頁、1961年〕、する
いはアコレプラズマ(A’cholep’1.asma
)由来の酵素、〔ヨーロピアン・ジャーナル・オブ・
バイオケミストリー(’EurcipeanJourn
al of BiocMmi8tr7 )第120巻、
第329頁、1981年〕、バチルス属(Bacil、
1us )由来の酵素しジャーナル・オプ・バイオケミ
ストリー(Journal of Bioche−mi
stry ) 第98巻、第1433頁、1985年
、特開昭65−25+082号〕等がおり、これらの酵
素は、精製物でも、未棺製物でもよい。Examples of the NAD(P)H oxidase in the present invention include those of the genus Brevibacterium (BrθVibac-ter
ium), Corynebacterium (Corynθti
aC-terium', l, Arthrobacterium (Ar
throbacter), Micrococcus spp. (MiCr
OCoccu8, Pseuaomo
Achromobacter spp.
er ), Agrobacterium spp.
rium), Flavobacterium (Flavobacterium
cterium), Stregutomyces (Strep
tomyces) reproduces <JP-A-65-44
No. 882, No. 63-157675), or rf1' derived from Lactobacillus (Agricultural &
Agricutural
andBiol,ogica'l Chemistry
y) Vol. 25, p. 876, 1961], or A'cholep'1.asma
) derived enzyme, [European Journal of
Biochemistry ('Eurcipean Journal)
al of BiocMmi8tr7) Volume 120,
329, 1981], Bacillus spp.
Journal of Biochemistry (Journal of Biochemistry)
stry) Volume 98, Page 1433, 1985, JP-A No. 65-25+082], and these enzymes may be purified products or undiluted products.
また、酵素標品は溶液状あるいは懸濁液でもよい。Further, the enzyme preparation may be in the form of a solution or suspension.
また本発明における陰イオン交換基を持つ担体としては
、例えばDEAE−セファロース(Sepharos’
e ) CL−6B、 DEAE−セファデックス(5
ephadex’)’A −25、DEAE−セファデ
ックスA−50、DEAE−セフアセA/ (5eph
ace1. )、QAE−セファデックスA−25、Q
AE−セファデックスA−50(以上ファルマシア社製
) 、 DEAE−トヨバール(TOYOPEARL
) 650M 、 DEAE −トヨバール65O8(
以上東洋曹達社製)、DEAF−セルロース(Ce11
ulose )、アムバーライト(Amberlite
) IRA−400[ダウエックス(Dowex)]
等があジ、隘イオン交換基を持つ担体ならばどんな物で
もよい。また、担体の形状は同相であればよく、樹脂状
でも膜状でも良い。In addition, as the carrier having an anion exchange group in the present invention, for example, DEAE-Sepharose (Sepharos'
e) CL-6B, DEAE-Sephadex (5
ephadex')'A-25, DEAE-Sephadex A-50, DEAE-Sephadex A/ (5eph
ace1. ), QAE-Sephadex A-25, Q
AE-Sephadex A-50 (manufactured by Pharmacia), DEAE-TOYOPEARL
) 650M, DEAE-Toyobar 65O8 (
(manufactured by Toyo Soda Co., Ltd.), DEAF-cellulose (Ce11)
ulose), Amberlite
) IRA-400 [Dowex]
Any carrier having an ion exchange group may be used. Further, the shape of the carrier only needs to be the same phase, and may be resin-like or film-like.
固定化の際の粂件は例えば10 mM リン版カリウム
緩衝液中で本酵素と例えは、本緩衝液で平衡化したDE
AE−セファデックスA−25をゆるやかに混合し、1
0分程度放置すればよい。緩衝液としてはトリス−塩酸
緩衝液やグリシン−水酸化ナトリウム緩衝液等でも良い
。次に、固定化酵素の洗浄を行う。洗浄剤としては例え
ば5〜20%食塩水溶液、好ましくは10%〜20係食
塩水溶液を用い、本酵素固定化担体を充分に洗浄すれば
よい。また、同程度のイオン強度を有する溶液であれば
、例えば5〜20%塩化カリウム水溶液や1Mリン酸カ
リウム緩trlJ液等も良い。For immobilization, for example, the present enzyme is prepared in a 10 mM potassium phosphate buffer, and the DE equilibrated with the present buffer is
Gently mix AE-Sephadex A-25 and add 1
Just leave it for about 0 minutes. The buffer may be a Tris-hydrochloric acid buffer, a glycine-sodium hydroxide buffer, or the like. Next, the immobilized enzyme is washed. As a cleaning agent, for example, a 5-20% saline solution, preferably a 10%-20% saline solution may be used to thoroughly wash the enzyme-immobilized carrier. Further, as long as the solution has a similar ionic strength, for example, a 5-20% potassium chloride aqueous solution or a 1M potassium phosphate mild trlJ solution may be used.
固定化NAD(P)Hオキシダーゼはカタラーゼ、グロ
テアーゼ等夾雑酵素が無く、(11NAD (P) H
オキシダーゼがNAD(P)Hに作用して生じた過酸化
水素がカタラーゼ寺の夾雑物質の作用により分解される
ことがなく、本固定化酵素の定菫性は良い、(21NA
D(P)Hオキシダーゼがグロテアーゼ等の夾雑物質の
作用により分解されることがなく、本固定化酵素の安定
性が良い等の特徴をもつ。The immobilized NAD (P) H oxidase is free of contaminant enzymes such as catalase and grotease, and is
The hydrogen peroxide produced by the action of oxidase on NAD(P)H is not degraded by the action of contaminants in catalase, and the fixed violet property of this immobilized enzyme is good (21NA).
D(P)H oxidase is not degraded by the action of contaminants such as grotease, and the immobilized enzyme has good stability.
実際、本固定化酵素を用いてNADHを酸化する実験を
行ったところ、NADHの特異吸収波長340nmの吸
光度の測定により求めたNADHの減少量と、過酸化水
素電極により測定した過酸化水素の増加蓋は一致してい
た。また本、酵素は調製後4℃にて保存した場合60日
後においても100%活性が保持されていた。In fact, when we conducted an experiment to oxidize NADH using this immobilized enzyme, we found that the amount of decrease in NADH was determined by measuring the absorbance at the specific absorption wavelength of 340 nm of NADH, and the increase in hydrogen peroxide was determined using a hydrogen peroxide electrode. The lids matched. Furthermore, when the present enzyme was stored at 4°C after preparation, 100% activity was maintained even after 60 days.
以下に本発明を実施例をもって説明するが、本発明が以
下の実施例の範囲のみに限定されるものではない。The present invention will be explained below with reference to examples, but the present invention is not limited to the scope of the following examples.
実施例1
ブレビバクテリウム アンモニアゲネス(Brevib
acterium ammoniagenes ) I
AM 1645株を特開昭63−44882号公報記載
の培養法のごとく培養、集菌し、この菌体2fを10m
M リン酸カリウム緩衝fi pH7,0に懸濁し、
超音波処理を施し粗酵素液20ゴを得た。上記粗酵素液
に、あらかじめ10mMリン酸カリウム緩衝液pH7,
0で平衡化しfC,DEAE−セファロースCL−6B
(10グ)を添加し、よくかくはん後、樹脂をガラス
f過器でf過し、樹脂を20%食塩浴液50−で洗浄後
、50mMリン酸カリウム緩衝液pH7,0にて十分洗
浄し固定化酵素を得た。Example 1 Brevibacterium ammoniagenes (Brevib
acterium ammoniagenes) I
AM1645 strain was cultured and collected according to the culture method described in JP-A No. 63-44882, and 2f of this bacterial body was grown in a 10 m
M suspended in potassium phosphate buffer fi pH 7.0,
20 pieces of crude enzyme solution were obtained by ultrasonication. Add 10mM potassium phosphate buffer (pH 7) to the above crude enzyme solution in advance.
Equilibrated at 0 fC, DEAE-Sepharose CL-6B
(10 g) was added, and after stirring well, the resin was filtered with a glass filter, and the resin was washed with 20% saline bath solution 50-50%, and then thoroughly washed with 50 mM potassium phosphate buffer pH 7.0. An immobilized enzyme was obtained.
実施例2
バチルス スフエリカス(Bacillus 5pha
e−ricus ) IFo 3341株を特開昭63
−251082号公報記載の培養方法のごとく培養、集
菌し、この菌体101を60mMリン酸カリウム緩衝液
pH7,2にm濁し超音波処理を施し粗酵素液40m1
を得た。この粗酵素液に、あらかじめ60n+M リ
ン酸カリウム緩衝液pH7,2で平衡化したDEAE−
セファロースCL−6B (10g)を添加し、よくか
くはん後ガラス濾過器でe過し、樹脂を10係食塩溶液
50−で洗浄後60凹リン酸カリウム緩WJ液pH7,
2にて十分洗浄し固定化酵素を得た。Example 2 Bacillus sphaericus (Bacillus 5pha)
e-ricus) IFo 3341 strain was published in 1986
The cells were cultured and collected according to the culture method described in Publication No. 251082, and the cells 101 were suspended in 60mM potassium phosphate buffer pH 7.2 and subjected to ultrasonication to produce 40ml of crude enzyme solution.
I got it. To this crude enzyme solution, add DEAE-
Sepharose CL-6B (10g) was added, stirred thoroughly, and filtered through a glass filter. The resin was washed with a 10% sodium chloride solution, 50%, and a 60% potassium phosphate mild WJ solution, pH 7.
2 to obtain an immobilized enzyme.
実施例3
実施例1と同様の方法で、各種微生物の生産するNAD
(P)Hオキシダーゼの固定化を行った。Example 3 NAD produced by various microorganisms in the same manner as in Example 1
(P)H oxidase was immobilized.
表1に示す様に固定化に供したすべての酵素で同定化N
AD(P)Hオキシダーゼが得られた。As shown in Table 1, the identified N
AD(P)H oxidase was obtained.
辰
実施例4
(a) 実施例1及び実施例2で得られた固定化酵素
を濃度0.2 mMのNADH溶液中に添加し37℃で
反応を行い、NADHの減少量の540 nmの吸光度
により測定し、過酸化水素の生成量を過酸化水素電極で
測定したところ、NAD Hの減少モル数と過酸化水素
の生成モル数は一致していた。Dragon Example 4 (a) The immobilized enzyme obtained in Example 1 and Example 2 was added to an NADH solution with a concentration of 0.2 mM, the reaction was carried out at 37°C, and the absorbance at 540 nm of the decrease in NADH was measured. When the amount of hydrogen peroxide produced was measured using a hydrogen peroxide electrode, the number of moles of NADH decreased and the number of moles of hydrogen peroxide produced matched.
(切 実施例1及び実施例2で得られた固定化酵素は4
℃で保存した場合30日後も同定化直後の活性を100
%保持した。(The immobilized enzyme obtained in Example 1 and Example 2 was
When stored at ℃, even after 30 days the activity immediately after identification is 100
% retained.
以上詳細に説明した様に、本発明によりNAD(P)
Hオキシダーゼを容易に、効率良く置屋化した、反応性
が良く、副反応が生じず、保存安定性の良い固定化酵素
が提供された。As explained in detail above, according to the present invention, NAD(P)
Provided is an immobilized enzyme that easily and efficiently stores H oxidase, has good reactivity, does not cause side reactions, and has good storage stability.
Claims (1)
ミドアデニンジヌクレオチド又は還元型のニコチンアミ
ドアデニンジヌクレオチドホスフェートに作用して、酸
化型のニコチンアミドアデニンジヌクレオチド又は酸化
型のニコチンアミドアデニンジヌクレオチドホスフェー
ト及び過酸化水素を発生させる酵素を固定化させたこと
を特徴とする固定化酵素。1. Oxidized nicotinamide adenine dinucleotide or oxidized nicotinamide adenine dinucleotide is added to a carrier having an anion exchange group by acting on reduced nicotinamide adenine dinucleotide or reduced nicotinamide adenine dinucleotide phosphate. An immobilized enzyme characterized by immobilizing an enzyme that generates nucleotide phosphate and hydrogen peroxide.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7489A JPH02182187A (en) | 1989-01-05 | 1989-01-05 | Immobilized enzyme |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7489A JPH02182187A (en) | 1989-01-05 | 1989-01-05 | Immobilized enzyme |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH02182187A true JPH02182187A (en) | 1990-07-16 |
Family
ID=11464025
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP7489A Pending JPH02182187A (en) | 1989-01-05 | 1989-01-05 | Immobilized enzyme |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH02182187A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009165417A (en) * | 2008-01-17 | 2009-07-30 | Keio Gijuku | New hydrogen peroxide-forming type nadh oxidase and dna encoding the same |
-
1989
- 1989-01-05 JP JP7489A patent/JPH02182187A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009165417A (en) * | 2008-01-17 | 2009-07-30 | Keio Gijuku | New hydrogen peroxide-forming type nadh oxidase and dna encoding the same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Schneider et al. | Purification and properties of soluble hydrogenase from Alcaligenes eutrophus H 16 | |
Kalisz et al. | Effects of carbohydrate depletion on the structure, stability and activity of glucose oxidase from Aspergillus niger | |
Cleere et al. | Avian xanthine dehydrogenases—I. Isolation and characterization of the turkey liver enzyme | |
Hasan et al. | Purification and properties of chorismate synthase from Bacillus subtilis. | |
Maki et al. | Studies on Monooxygenases: II. Crystallization and some properties of imidazole acetate monooxygenase | |
Simonetta et al. | Purification and properties of d-amino-acid oxidase, an inducible flavoenzyme from Rhodotorula gracilis | |
WO1987007639A1 (en) | Process for preparing a catalase-free oxidase and a catalase-free oxidase-containing yeast, and use thereof | |
JPH02182187A (en) | Immobilized enzyme | |
EP0142169A2 (en) | 2,5-Diketo-D-gluconic acid reductase | |
JP3041840B2 (en) | Novel glycerol dehydrogenase, its production method and its use | |
JPS61111685A (en) | Stabilized enzyme and its preparation | |
JPH0134035B2 (en) | ||
Persson et al. | Continuous regeneration of NAD (H) covalently bound to a cysteine genetically engineered into glucose dehydrogenase | |
Tamegai et al. | Two membrane-bound c-type cytochromes of Thiobacillus ferrooxidans: purification and properties | |
Coughlan et al. | Preparation and properties of immobilised xanthine oxidase | |
Kapmeyer et al. | A transition state analog for two pyruvate metabolizing enzymes, lactate dehydrogenase and alanine dehydrogenase | |
Vincke et al. | Analytical determination of nicotinamide using bacterial electrodes | |
JPH02268679A (en) | Production of 1,5-anhydroglycitol dehydrogenase | |
JPS5915625B2 (en) | Novel acyl coenzyme A oxidase and its production method | |
Nakanisi et al. | A simple procedure for purification of NADH-specific dihydropteridine reductase from mammalian liver | |
Borneleit et al. | Purification and properties of the membrane-bound NADH dehydrogenase from hydrocarbon-grown Acinetobacter calcoaceticus | |
JPS6078579A (en) | 2-oxocarboxylic acid reductase and production | |
JP3152855B2 (en) | Novel sorbitol dehydrogenase, method for producing the same, reagent and method for quantifying sorbitol using the enzyme | |
JP2768473B2 (en) | Method for producing NADH oxidase | |
Trivić et al. | Bioorganic mechanisms of the formation of free radicals catalyzed by glucose oxidase |